Cervical lymph node relapses of head-and-neck squamous cell carcinoma: Is brachytherapy a therapeutic option?

被引:26
作者
Bollet, MAA
Lapeyre, M
Marchal, C
Hoffstetter, S
Peiffert, D
Cornes, PGS
Luporsi, E
Bey, P
机构
[1] Ctr Alexis Vautrin, Brachytherapy Unit, F-54511 Vandoeuvre Les Nancy, France
[2] Ctr Alexis Vautrin, Dept Radiotherapy, F-54511 Vandoeuvre Les Nancy, France
[3] Ctr Alexis Vautrin, Dept Stat, F-54511 Vandoeuvre Les Nancy, France
[4] Royal Marsden Hosp, Dept Radiotherapy, Sutton, Surrey, England
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 51卷 / 05期
关键词
interstitial brachytherapy; lymph node relapse; squamous cell carcinoma; head-and-neck cancer; salvage treatment;
D O I
10.1016/S0360-3016(01)01725-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To report the results of interstitial brachytherapy (IBT) without salvage surgery for isolated cervical lymph node relapses. Patients and Methods: From 1970 to 1989, 84 patients were treated; 76 patients had relapsed in sites of previous external beam radiation. In 72 patients, IBT was sole salvage treatment (mean, 56.5 Gy). In 12 patients IBT (mean, 38 Gy) was combined with further external beam radiotherapy (mean, 41 Gy). Results: Local control in the neck was 49% at 1 year, 31% at 2 years, and 0% at 5 years. Overall survival was 33% at 1 year, 13 % at 2 years, and 1 % at 5 years. Significant toxicity occurred in 35% (7% fatal). Multivariate analysis shows survival after salvage was better for patients who had achieved initial control for greater than or equal to 18 months before relapse (0% vs. 13% at 3 years, p < 0.0002). Lymph node control was better for patients who received total salvage dose <greater than or equal to>60 Gy (0% vs. 56% at 3 years, p = 0.0004). Conclusion: Given its poor efficiency and its toxicity, IBT must be considered only when surgery is contraindicated and if lymph node relapse occurs after a minimal interval of 18 months. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:1305 / 1312
页数:8
相关论文
共 36 条
[1]  
ADELSTEIN DJ, 1994, SEMIN ONCOL, V21, P52
[2]  
Barzan L, 1996, ARCH OTOLARYNGOL, V122, P1299
[3]   REGIONAL OUTCOME IN OROPHARYNGEAL AND PHARYNGOLARYNGEAL CANCER TREATED WITH HIGH-DOSE PER FRACTION RADIOTHERAPY - ANALYSIS OF NECK DISEASE RESPONSE IN 1646 CASES [J].
BERNIER, J ;
BATAINI, JP .
RADIOTHERAPY AND ONCOLOGY, 1986, 6 (02) :87-103
[4]  
CHAUVEL P, 1982, ACTUALITES CARCINOLO, V7
[5]  
CHOO R, 1993, J OTOLARYNGOL, V22, P54
[6]   Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction [J].
Cornes, PGS ;
Cox, HJ ;
RhysEvans, PR ;
Breach, NM ;
Henk, JM .
BRITISH JOURNAL OF SURGERY, 1996, 83 (11) :1620-1622
[7]   Complications from planned, posttreatment neck dissections [J].
Davidson, BJ ;
Newkirk, KA ;
Harter, KW ;
Picken, CA ;
Cullen, KJ ;
Sessions, RB .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (04) :401-405
[8]  
DESANTO LW, 1982, LARYNGOSCOPE, V92, P502
[9]  
DUTREIX M, 1987, MODERN BRACHYTHERAPY, P25
[10]   SALVAGE SURGERY OF CERVICAL RECURRENCES AFTER NECK DISSECTION OR RADIOTHERAPY [J].
GRANDI, C ;
MINGARDO, M ;
GUZZO, M ;
LICITRA, L ;
PODRECCA, S ;
MOLINARI, R .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (04) :292-295